Zynerba Pharmaceuticals, Inc. (ZYNE) Strikes New 52-Week High

On Thursday Shares of Zynerba Pharmaceuticals, Inc. (ZYNE) were valued at $15.50 and moved 11.35% as of a recent closing trade. A total volume of 5.38 million shares were traded versus to average volume of 2.35 million shares.


Zynerba Pharmaceuticals, Inc. (ZYNE) held 19.76 million outstanding shares currently. The company have shares float of 18.17 million. Now have a look at past performance (weekly performance to year to date performance) how Zynerba Pharmaceuticals, Inc. (ZYNE) has been moved; whether it performed well or not. ZYNE reported a change of 29.60% over the last week and performed 86.75% over the last month while its year to date (YTD) performance revealed an activity trend of 421.89%. The stock’s quarterly performance specifies a shift of 190.81%, and its last twelve month performance is stands at 63.67% while moved 173.85% for the past six months.

Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. ZYNE recently closed with rise of 35.88% to its twenty-Day SMA. This short time frame picture represents an upward movement of current price over average price of last twenty days.

52 week High and Low

Zynerba Pharmaceuticals, Inc. (ZYNE) shares have been seen trading 9.54% off its 52 week- peak value and changed 463.64% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.

Analysts have suggested a mean rating of 1.80 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

Relative Strength Index (RSI)

Zynerba Pharmaceuticals, Inc. (ZYNE)’s Relative Strength Index (RSI) is 80.15. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for Zynerba Pharmaceuticals, Inc. (ZYNE) is stands at 1.18. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.

Over the past week, the company showed volatility of 8.90%. Moving out to look at the previous month volatility move, the stock is at 11.34%.

Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is 5.56.

Jessie Leiser

Jessie Leiser is an experienced writer, editor and proofreader. She covers all Acquisition & Merger news of different companies. These companies registered on US exchanges i.e. NYSE, NASDAQ, AMEX, NYSEMKT etc. Jessie completed her Post-Graduate Diploma in Business Administration with a specialization in Finance from International School of Business and Media (ISB&M). She is married and lives in sunny West Central Florida with her husband and two children.

Leave a Reply

Your email address will not be published. Required fields are marked *